Yi Sun

23.5k total citations · 4 hit papers
287 papers, 18.5k citations indexed

About

Yi Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yi Sun has authored 287 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 238 papers in Molecular Biology, 111 papers in Oncology and 63 papers in Cancer Research. Recurrent topics in Yi Sun's work include Ubiquitin and proteasome pathways (126 papers), Cancer-related Molecular Pathways (78 papers) and Autophagy in Disease and Therapy (30 papers). Yi Sun is often cited by papers focused on Ubiquitin and proteasome pathways (126 papers), Cancer-related Molecular Pathways (78 papers) and Autophagy in Disease and Therapy (30 papers). Yi Sun collaborates with scholars based in United States, China and Canada. Yi Sun's co-authors include L. W. Oberley, Yi Li, Mingjia Tan, Yongchao Zhao, Xiufang Xiong, Lijun Jia, Nancy H. Colburn, Meredith A. Morgan, Larry W. Oberley and Hua Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Yi Sun

274 papers receiving 18.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A simple method for clinical assay of superoxide dismutase.

1988 3.8k citations Yi Sun et al. profile →
Free radicals, antioxidant enzymes, and carcinogenesis

1990 934 citations Yi Sun profile →
Redox regulation of transcriptional activators

1996 569 citations Yi Sun et al. profile →
Protein neddylation and its role in health and diseases

2024 57 citations Yi Sun et al. Signal Transduction and Targeted Therapy profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Yi Sun	11.2k	4.3k	2.8k	1.7k	1.7k	287	18.5k
Ann M. Bode	12.4k 1.1×	4.1k 1.0×	3.3k 1.2×	1.6k 0.9×	1.6k 1.0×	422	21.1k
Thomas G. Cotter	11.8k 1.1×	2.6k 0.6×	1.8k 0.6×	2.6k 1.5×	1.3k 0.8×	244	18.4k
Philippe Marchetti	9.9k 0.9×	2.4k 0.6×	1.6k 0.6×	2.3k 1.4×	1.3k 0.8×	177	16.1k
Bernd Kaina	14.5k 1.3×	5.6k 1.3×	5.1k 1.8×	1.4k 0.8×	1.1k 0.7×	328	21.1k
James A. McCubrey	16.1k 1.4×	6.8k 1.6×	3.9k 1.4×	3.2k 1.8×	1.6k 1.0×	421	24.9k
Zigang Dong	17.1k 1.5×	5.7k 1.3×	4.4k 1.6×	2.2k 1.3×	2.4k 1.5×	578	28.0k
Donald P. McDonnell	11.6k 1.0×	4.3k 1.0×	3.5k 1.3×	2.3k 1.3×	908 0.5×	272	23.8k
Catherine Brenner	10.9k 1.0×	1.7k 0.4×	1.6k 0.6×	1.8k 1.1×	1.4k 0.8×	139	16.4k
Douglas R. Spitz	12.1k 1.1×	2.2k 0.5×	3.8k 1.4×	1.3k 0.8×	1.1k 0.6×	300	22.1k
Jing Liu	8.9k 0.8×	1.8k 0.4×	2.3k 0.8×	1.3k 0.8×	715 0.4×	564	15.4k

Countries citing papers authored by Yi Sun

Since Specialization

Citations

This map shows the geographic impact of Yi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Sun more than expected).

Fields of papers citing papers by Yi Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Sun. The network helps show where Yi Sun may publish in the future.

Co-authorship network of co-authors of Yi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Sun. A scholar is included among the top collaborators of Yi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Sun. Yi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Lei, Bo Li, Qiang Li, et al.. (2025). UBE2C-mediated ubiquitination of ACSL4 inhibits ferroptosis and promotes gastric cancer progression. Discover Oncology. 16(1). 1557–1557.

Liu, Lihua, Yan Yin, Qian Chen, et al.. (2025). Discovery of LD-110 as an Effective LSD1 PROTAC Degrader for the Treatment of Esophagus Squamous Cancer. Journal of Medicinal Chemistry. 68(20). 21860–21877. 1 indexed citations

Zhang, Yun, Lijun Du, Chenxi Wang, et al.. (2024). Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis. Signal Transduction and Targeted Therapy. 9(1). 18–18. 17 indexed citations

Chen, Qian, Xiufang Xiong, & Yi Sun. (2024). USP10 deubiquitylates and stabilizes DIRAS2 to suppress the growth of pancreatic cancer cells. SHILAP Revista de lepidopterología. 5(10). e751–e751. 1 indexed citations

Kang, Haiquan, Ziling Wang, Jingfang Sun, et al.. (2024). Rapid identification of bloodstream infection pathogens and drug resistance using Raman spectroscopy enhanced by convolutional neural networks. Frontiers in Microbiology. 15. 1428304–1428304. 8 indexed citations

Wu, Xiaojin, et al.. (2024). The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping. Annals of Hematology. 103(3). 917–933. 3 indexed citations

Sun, Yi, et al.. (2024). A retrospective study to determine the correlation among HBV PreS1 antigen, HBV e antigen, alanine aminotransferase, and HBV DNA. Clinics and Research in Hepatology and Gastroenterology. 48(6). 102369–102369.

Wang, Wenjuan, Ermin Li, Jianqiu Zou, et al.. (2024). Ubiquitin Ligase RBX2/SAG Regulates Mitochondrial Ubiquitination and Mitophagy. Circulation Research. 135(3). e39–e56. 7 indexed citations

Han, Xin & Yi Sun. (2023). PROTACs: A novel strategy for cancer drug discovery and development. SHILAP Revista de lepidopterología. 4(3). e290–e290. 27 indexed citations

10.

Li, Yanan, Di Wu, Haomin Li, & Yi Sun. (2023). Inactivation of Rbx1 E3 ligase suppresses Kras^G12D‐driven lung tumorigenesis. SHILAP Revista de lepidopterología. 4(4). e332–e332. 2 indexed citations

11.

Li, Chenhui, Lele Zhang, Hai Hu, et al.. (2021). RNF111-facilitated neddylation potentiates cGAS-mediated antiviral innate immune response. PLoS Pathogens. 17(3). e1009401–e1009401. 37 indexed citations

12.

Zhou, Weihua, Jie Xu, Haomin Li, et al.. (2016). Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage. Clinical Cancer Research. 23(4). 1104–1116. 92 indexed citations

13.

Wei, Dongping, Leslie A. Parsels, David Karnak, et al.. (2013). Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair. Clinical Cancer Research. 19(16). 4422–4432. 80 indexed citations

14.

Luo, Zhongguang, Guangyang Yu, Hyuk Woo Lee, et al.. (2012). The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth. Cancer Research. 72(13). 3360–3371. 202 indexed citations

15.

Wei, Dongping, Hua Li, Jie Yu, et al.. (2011). Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor. Cancer Research. 72(1). 282–293. 136 indexed citations

16.

Yang, Jie, Donna McEachern, Wenyan Li, et al.. (2011). Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases. Molecular Cancer Therapeutics. 10(4). 658–669. 43 indexed citations

17.

Jia, Lijun, Jie Yang, Xinbao Hao, et al.. (2010). Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target. Clinical Cancer Research. 16(3). 814–824. 81 indexed citations

18.

Jia, Lijun, Marı́a S. Soengas, & Yi Sun. (2009). ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence. Cancer Research. 69(12). 4974–4982. 109 indexed citations

19.

Wang, Zhen, Min Zheng, Zhichuan Li, et al.. (2009). Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK Inhibition. Cancer Research. 69(16). 6556–6564. 83 indexed citations

20.

Lü, Jianfeng, Longchuan Bai, Haiying Sun, et al.. (2008). SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP. Cancer Research. 68(22). 9384–9393. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact